Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cara Therapeutics (CARA)
NASDAQ:CARA
Cara Therapeutics (CARA) Ownership - Who Owns Cara Therapeutics?
2,186 Followers
Cara Therapeutics (CARA) Ownership Overview
14.27% Insiders
15.78% Mutual Funds
11.51% Other Institutional Investors
58.44% Public Companies and Individual Investors
The ownership structure of Cara Therapeutics (CARA) stock is a mix of institutional, retail and individual investors. Approximately 27.29% of the company’s stock is owned by Institutional Investors, 14.27% is owned by Insiders and 58.44% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $12697 | |
| Dec 31, 2023 | Sold | $1156294 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,375,650 | Institution | 4.35% | 1,624,945 | |
| 2,000,066 | Institution | 3.66% | 1,368,045 | |
| 1,694,129 | Institution | 3.10% | 1,158,784 | |
| 1,556,251 | Institution | 2.85% | 1,064,476 | |
| 1,314,338 | Insider | 2.40% | 899,007 | |
| 991,405 | Insider | 1.81% | 678,121 | |
| 800,390 | Institution | 1.46% | 547,467 | |
| 631,351 | Institution | 1.15% | 431,844 | |
| 580,163 | Institution | 1.06% | 396,831 | |
| 495,806 | Institution | 0.91% | 339,131 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,000,066 | Institution | 3.66% | 1,368,045 | |
| 800,390 | Institution | 1.46% | 547,467 | |
| 580,163 | Institution | 1.06% | 396,831 | |
| 495,806 | Institution | 0.91% | 339,131 | |
| 477,811 | Institution | 0.87% | 326,823 | |
| 464,908 | Institution | 0.85% | 317,997 | |
| 396,991 | Institution | 0.73% | 271,542 | |
| 322,039 | Institution | 0.59% | 220,275 | |
| 321,160 | Institution | 0.59% | 219,673 | |
| 274,682 | Institution | 0.50% | 187,882 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,354,313 | Institution | 2.48% | 1,232,425 | |
| 1,152,722 | Institution | 2.11% | 788,808 | |
| 645,753 | Institution | 1.18% | 587,635 | |
| 402,286 | Institution | 0.74% | 486,766 | |
| 430,520 | Institution | 0.79% | 294,605 | |
| 85,821 | Institution | 0.16% | 288,359 | |
| 173,867 | Institution | 0.32% | 158,219 | |
| 222,733 | Institution | 0.41% | 155,913 | |
| 167,055 | Institution | 0.31% | 152,020 | |
| 11,720 | Institution | 0.02% | 142,398 |
FAQ
Who Owns Cara Therapeutics (CARA)?
According to the latest TipRanks data, approximately 11.51% of the company's stock is held by institutional investors, 14.27% is held by insiders, and 58.44% is held by retail investors.
What percentage of Cara Therapeutics (CARA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.51% of Cara Therapeutics (CARA) stock is held by institutional investors.
What percentage of Cara Therapeutics (CARA) stock is held by retail investors?
According to the latest TipRanks data, approximately 58.44% of Cara Therapeutics (CARA) stock is held by retail investors.
Who owns the most shares of Cara Therapeutics (CARA)?
Vanguard owns the most shares of Cara Therapeutics (CARA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.